ADRA2B Antikörper (Center, Internal Region)
Kurzübersicht für ADRA2B Antikörper (Center, Internal Region) (ABIN2196821)
Target
Alle ADRA2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Center, Internal Region
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- ADRA2B, ID (Alpha-2B Adrenergic Receptor, Alpha-2B Adrenoreceptor, Alpha-2B Adrenoceptor, Alpha-2BAR, Alpha-2 Adrenergic Receptor Subtype C2, ADRA2L1, ADRA2RL1)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- Synthetic peptide selected from the Center region of human ADRA2B (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
-
Andere Bezeichnung
- ADRA2B
-
NCBI Accession
- NP_000673
-
UniProt
- P18089
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-